|
|
Volumn 9, Issue 2, 2008, Pages 75-76
|
|
Bevacizumab/chemotherapy in non-small-cell lung cancer: Looking for a few good men?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTICOAGULANT AGENT;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
BIOLOGICAL MARKER;
CARBOPLATIN;
CEDIRANIB;
CYTOTOXIC AGENT;
ERLOTINIB;
PACLITAXEL;
PROTEIN TYROSINE KINASE INHIBITOR;
SORAFENIB;
VANDETANIB;
VASCULOTROPIN ANTIBODY;
VASCULOTROPIN INHIBITOR;
ACCURACY;
ADVANCED CANCER;
AREA UNDER THE CURVE;
BLEEDING;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER DIAGNOSIS;
CANCER GROWTH;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMORBIDITY;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
EDITORIAL;
ELDERLY CARE;
HEMOPTYSIS;
HISTOPATHOLOGY;
HUMAN;
LUNG NON SMALL CELL CANCER;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
PATIENT CARE;
PLEURA EFFUSION;
RASH;
RISK FACTOR;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
|
|
EID: 43049130375
PISSN: 15257304
EISSN: None
Source Type: Journal
DOI: 10.3816/CLC.2008.n.011 Document Type: Editorial |
|
Times cited : (4)
|
|
References (2)
|
